The Task Force model holds tremendous promise for addressing future global health challenges. Collaboration and science will continue to be the foundation of all our work.
Over the next decade, The Task Force will continue to work toward reaching elimination goals for blinding trachoma, river blindness, and lymphatic filariasis. In addition, The Task Force is a partner with Emory University’s Global Health Institute and the Centers for Disease Control and Prevention on a 20-year initiative funded by the Bill & Melinda Gates Foundation called the Child Health and Mortality Prevention Surveillance program (CHAMPS). This program is working to understand and address the causes of serious illness and death among children under age 5 in sub-Saharan African and South Asian countries that experience high rates of child mortality.
'We Will Eliminate Blinding Trachoma'
- Caroline Roan
Vice President of Corporate Responsibility at Pfizer Inc
Anticipated Focus Areas
In late 2016, we plan to begin work with the World Health Organization African Region to help implement the “Transformation Agenda” for improved health security and strengthened health systems on the continent.
The epidemic of noncommunicable diseases such as diabetes and cancer represents an increasing burden for developed and developing countries alike. We are considering how we might apply our core competencies to addressing specific aspects of noncommunicable diseases in the coming years.
We are already leveraging our expertise in informatics, program management, and surveillance to ensure our programs reach their potentials. As we look to reach more people, program integration will also be an increasing focus at The Task Force.